Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Shanghai S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 18.79 CNY | +1.51% |
|
+3.53% | +6.64% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 14.41x | 2.73x | 0.7x | 0.61x | 4.72x | 7.77x | 5.01% | 3.19B | |
| 16.91x | 1.53x | 1.63x | 0.69x | 10.24x | 11.14x | -.--% | 15.07B | |
| 16.81x | 1.73x | 1.61x | 0.76x | 7.89x | 9.89x | 2.22% | 6.55B | |
| 20.89x | 2.32x | 2.72x | 0.8x | 13.4x | 13.66x | 1.07% | 6.47B | |
| 14.69x | 2.18x | 1x | 0.9x | 6.23x | 8.47x | 2.88% | 4.14B | |
| 14.27x | 4.32x | 23.84x | 1.23x | 7.5x | 14.07x | 5.64% | 3.17B | |
| 13.8x | 6.24x | 2.11x | 0.83x | 6.23x | 8.66x | 4.67% | 2.94B | |
| 33.21x | - | 0.58x | - | - | - | - | 2.58B | |
| 19.42x | 3.4x | 0.84x | 0.57x | 7.29x | 11.93x | 2.09% | 1.46B | |
| -124.28x | 2.55x | 1.67x | 0.43x | 15.25x | 65.89x | 0.02% | 1.42B | |
| 13.92x | 0.87x | 0.18x | 0.29x | 2.68x | 6.74x | 3.32% | 963M | |
| 20.22x | 2.38x | -0.4x | 0.82x | 7.57x | 18.02x | 6.11% | 867M | |
| 39.55x | 3.78x | -6.08x | 0.92x | 11.52x | 22.69x | - | 861M | |
| 27.66x | 7.54x | 1.02x | 1x | 13.64x | 21.15x | 1.29% | 841M | |
| 14.06x | 1.9x | 1.16x | 0.68x | 8.29x | 13.38x | 0.37% | 717M | |
| Average | 10.37x | 3.10x | 2.17x | 0.75x | 8.75x | 16.68x | 2.67% | 3.42B | |
| Weighted average by Cap. | 14.21x | 2.50x | 2.78x | 0.76x | 9.13x | 12.97x | 1.96% |
Select your edition
All financial news and data tailored to specific country editions
